Filter
1988
Filtered Results: 1988
Text search:
hiv
drug
resistance
Featured
Recommendations
215
New Publications
583
Language
Document type
No document type
1340
Guidelines
241
Studies & Reports
225
Manuals
61
Strategic & Response Plan
46
Fact sheets
30
Training Material
26
Situation Updates
11
Infographics
7
Videos
1
Countries / Regions
India
99
South Africa
68
Kenya
59
Western and Central Europe
57
Ethiopia
45
Tanzania
42
Eastern Europe
42
Uganda
40
Zambia
37
Global
35
Nepal
34
Nigeria
33
Malawi
31
Africa
28
Liberia
28
Sierra Leone
27
Ghana
25
Rwanda
23
Asia
23
Bangladesh
23
Namibia
23
Lesotho
22
Philippines
20
Cambodia
20
Myanmar / Burma
20
Zimbabwe
18
Latin America and the Carribbean
18
Ukraine
17
Russia
14
South–East Asia Region
13
Botswana
13
Indonesia
13
Senegal
12
Mozambique
10
Cameroon
8
Albania
8
Eswatini/ Swaziland
8
Colombia
7
Burkina Faso
7
Thailand
6
Congo, Democratic Republic of
6
Argentina
6
Pakistan
6
Venezuela
5
Germany
5
Georgia
5
West and Central Africa
4
Middle East and North Africa
4
East and Southern Africa
4
Vietnam
4
North Macedonia
3
Tajikistan
3
Benin
3
Estonia
3
Guinea
3
Haiti
3
Jordan
3
Eastern Europe and Central Asia
3
El Salvador
2
Syria
2
Iran
2
Laos
2
Armenia
2
Western Pacific Region
2
Lebanon
2
Papua New Guinea
2
Moldova
2
Sudan
2
Central African Republic
2
Bhutan
2
Somalia
2
Switzerland
1
Timor Leste/ East Timor
1
Turkey
1
Gambia
1
China
1
Kazakhstan
1
Afghanistan
1
Peru
1
Morocco
1
Qatar
1
USA
1
Saudi Arabia
1
Paraguay
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Brazil
1
Sri Lanka
1
Romania
1
Greece
1
Mali
1
South Sudan
1
Iraq
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
770
Clinical Guidelines
227
Public Health
64
Women & Child Health
64
Key Resources
32
Capacity Building
24
Pharmacy & Technologies
23
Annual Report MEDBOX
1
Toolboxes
TB
452
HIV
347
AMR
144
Mental Health
46
Pharmacy
44
NTDs
39
COVID-19
37
Caregiver
32
Rapid Response
28
Refugee
26
Ebola
23
Global Health Education
19
Polio
15
Planetary Health
12
NCDs
11
Health Financing Toolbox
9
Conflict
9
Cholera
8
Disability
5
Natural Hazards
4
Zika
2
Specific Hazards
1
Social Ethics
1
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes.
This is photomicrograph ...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
The Country Cooperation Strategy is the World Health Organization’s corporate framework developed in response to a country’s needs and priorities. The 2022–2025 CCS is the fourth for WHO in Sierra Leone. It is a medium-term strategic document that defines a broad framework for WHO’s work, at...
This report highlights the work of the World Health Organization (WHO) in Zimbabwe towards contributing to the triple billion targets in the context of the Sustainable Development Goals (SDGs
The environment in which young people live, learn and play significantly affects their decisions about whether to consume alcohol. Environmental factors are the main risk factors driving alcohol consumption and related harm among young people. Environments that normalize alcohol consumption – term...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
The purpose of this workbook is to assist ministries of health, health managers and practitioners in engaging with the private sector on delivery of quality maternal, newborn and child health (MNCH) services in lower- and middle-income countries. Private health care is one of the fastest growing seg...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Diabetes is a major public health problem. The rising incidence of Diabetes Type 2 is related to the effects of urbanization and unhealthy lifestyles. Research studies show that healthy eating and regular physical activity can prevent or delay the onset of Diabetes Type 2, even in high-risk individu...
The document "Management of Type 2 Diabetes Mellitus" provides comprehensive guidelines for the diagnosis, prevention, and treatment of type 2 diabetes in adults. It emphasizes the importance of individualized glycemic targets, lifestyle interventions like diet and exercise, and the use of medicatio...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
Pneumonia and diarrhoea account for 23% of under-five mortality and were responsible for an estimated 1.17 million deaths in children under five globally. Furthermore, pneumonia and diarrhoea were responsible for 18% of mortality in children 5–9 years of age, resulting in an estimated 86 000 preve...
